Por: Fox Business Business October 11, 2023
FOX Business host Charles Payne reacts to the 'crisis of trust' in the United States on 'Making Money.' British pharmaceutical company GSK plc settled another lawsuit that claimed its Zantac can cause cancer. The company said Wednesday that it has reached a confidential settlement in the Cantlay/Harper case that was filed in California. The settlement was reached before the trial in that case was slated to begin on November... + full article
WPTV USA Nation November 03, 2023
Global drugmaker GSK Plc is buying access to 23andMe's vast collection of consumer for the price of $20 million.The company announced Monday it would be extending its five-year collaboration with GSK to allow the London-based pharmaceutical company one year of data... + más
23andMe profile information of some customers surfaces on dark web | Fox Business
Want to help with COVID-19 research? Those who tested positive can share their genetic makeup with DNA testing sites like 23andMe and Ancestry.com. | Chicago Tribune
Time USA Health March 03, 2023
GSK Plc’s vaccine for won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against Pfizer Inc. to bring to market the first vaccine for RSV. The panel of 12 outside advisers to the Food and Drug Administration... + más
FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks | CNBC
GSK vaccine for older adults granted FDA priority review | Fox Business
CNBC USA Health March 01, 2023
watch nowVIDEO1:5501:55FDA advisory panel votes in favor of adult RSV vaccine from GSK PLCThe Food and Drug Administration's independent panel of advisors on Wednesday recommended RSV vaccine for adults ages 60 and older, though they flagged potential safety issues over... + más
FDA Panel Backs GSK’s RSV Vaccine for Older People | Time
WPTV USA Nation December 07, 2022
Drugmakers including Boehringer Ingelheim, GSK Plc, Sanofi SA and Pfizer Inc saw a judge rule in their favor on Tuesday after facing thousands of lawsuits in U.S. federal court over claims the heartburn drug Zantac that they marketed at different times caused cancer. As Reuters... + más
GSK settles 4 Zantac lawsuits claiming heartburn drug caused cancer | Fox Business
GSK 3Q Sales Expected Lower, But Possible Guidance Upgrade on the Horizon -- Earnings Preview | MarketWatch
MarketWatch USA Business November 02, 2022
Operating profit was GBP1.19 billion, down slightly from GBP1.38 billion, due to the fair-value loss on the retained stake in consumer-healthcare business Haleon, which was spun off earlier in the year. Total earnings per share also fell to 18.8 pence from 21.9 pence for the... + más
GSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- Update | MarketWatch
Fox Business USA Business November 02, 2022
Check out what's clicking on FoxBusiness.com GSK opened 2% higher in U.S. trading Wednesday but closed down 2%. Shares rose after the drugmaker reported financial results that beat Wall Street forecasts and announced the Food and Drug Administration had accepted a biologics... + más
MarketWatch USA Business October 31, 2022
NET INCOME: Net income at the British pharma major is expected to increase only slightly to GBP1.62 billion from GBP1.17 billion the year prior, according to a company-provided consensus. EPS: Earnings per share are expected at 40.1 pence, from 23.1 pence the previous year. WHAT... + más
Horizon Worlds metaverse app so bad that Meta has to force employees to use it | 9to5Mac
Meta’s VR social network Horizon is too buggy and employees are barely using it | The Verge
About iurex | Privacy Policy | Disclaimer |